SY-9453

· Shouyao Holdings (Beijing) Co. LTD

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SY-9453, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors [Phase 1]